Physician profile
Ignacio Ripoll
NPI 1760489363
$11,096.76
in general payments reported to CMS, 2019-2025
42 companies · $627 in 2025
The $627 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,910 · 2020: $1,240 · 2021: $1,690 · 2022: $2,742 · 2023: $1,446 · 2024: $1,442 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,290 · Education: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,290.45 |
| Education | $224.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,633.52 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $1,433.47 | 2019-2024 | Tezspire, Airsupra, Breztri |
| Inspire Medical Systems, INC. | $1,091.27 | 2022-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,028.30 | 2019-2025 | Xywav |
| Harmony Biosciences LLC | $874.19 | 2020-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $611.26 | 2019-2025 | Uptravi, Opsumit |
| Mallinckrodt Hospital Products INC. | $411.85 | 2020-2022 | |
| Novo Nordisk INC | $401.31 | 2019-2025 | Wegovy |
| Axsome Therapeutics, INC. | $354.66 | 2022-2025 | Sunosi |
| Grifols USA, LLC | $278.22 | 2019-2022 | |
| Amgen INC. | $246.20 | 2021-2025 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $211.83 | 2023-2024 | Lumryz |
| Baxter Healthcare | $184.70 | 2022-2023 | |
| Insmed, INC. | $171.79 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $158.40 | 2019-2025 | Dupixent |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignacio Ripoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.